Battlement Capital
Battlement Capital is a research driven Australian Fund Manager established to provide Wholesale and Sophisticated Investors the opportunity to acquire shares in late-stage pre-IPO technology companies from existing shareholders. Partners of Battlement Capital have arranged or invested in more th…
battlementcapital.vc ↗Stage focus
Focus
Details
- Type
- Private Equity, Venture Capital
- Instrument
- equity
- Founded
- 2018
- Headquarters
- Sydney, Australia
Similar investors in Australia
Lux Capital
Mr. Tuvia Barak serves as Board Member at WeatherBell Analytics. Mr. Tuvia Barak serves as Venture Partner at Lux Capital. In 1982, Mr. Barak joined Tadiran, the North American subsidiary of Tadiran, the largest electronics conglomerate in Israel. During his 12-year tenure, over $3 billion in revenue was achieved under his direction, and Tadiran became one of the major suppliers of tactical communications to the U.S. Army. Mr. Barak developed strategic alliances and partnerships with some of the largest aerospace and defense companies. In 1993, Mr. Barak established his own marketing and consulting practice, advising U.S. and international companies on business development, marketing strategies, technology assessment, and mergers and acquisitions in the aerospace and technology fields. Mr. Barak is a member of the Board of Directors of Skyline Software, Arinc Corp., WhiteCanyon Software, Funley's Delicious, and Toonimo and special advisor to Siluria Technologies, Kymeta Corp., and Heller Industries. His many clients have included The Carlyle Group, Boeing, L-3 Communications, ITT, General Dynamics, AAI/Textron, BAE, EDS, DRS, Elbit Systems, Schott, Selex, Ness Technologies, Vought Aircraft, SanDisk, United Defense, Mantech International, NanoSys, MapInfo, Rockwell Collins and Raytheon. Mr. Barak has a M.Sc. in E.E. from the Technion Institute of Technology, Israel.
arcadia capital
Arcadia Capital is a mid-market private equity firm focused on acquiring growth companies in Australia and New Zealand. The firm was founded by two former colleagues from The Carlyle Group, one of world’s largest and most successful private equity firms. In founding Arcadia, Leigh and Sam identified an opportunity to apply the sophistication and discipline of global private equity to partnering with smaller businesses, a market which has historically been under-served by other private equity fun
arrowhead capital management
Arrowhead Capital Management (ArrowCap) is an impact focused Venture Capital and Private Equity firm that specialises in investing and working with high-growth oriented businesses. We adopt a diversified investment strategy that supports investments in a wide range of businesses that have potential to grow domestically, and into global markets. We like to understand entrepreneurs and management of our investments as individuals. We appreciate originality and realise greatness doesn't have a ster
Deepdale Group
Deepdale Group builds and scales Australian businesses that make everyday life healthier, smarter, and more sustainable. Our brands make the right kind of impact, creating value for clients and communities while prioritising social and environmental responsibilities. We're bringing innovations to new markets, multiplying value for our shareholders, and creating long-term employment opportunities with a culture of humour, respect, and curiosity.
Yuuwa Capital
James is an accomplished scientist, entrepreneur and investor. He has been involved from concept to commercialisation, including CEO, CTO and Board roles, of numerous biotech companies which have resulted in five FDA approved drugs and devices. He conceived the technology behind iCeutica Inc (acquired in 2011) and co-discovered the lead therapy for ASX-listed Dimerix Limited (ASX:DXB), currently in Phase 3 trials for Chronic Kidney Disease.
Artesian
Artesian Capital Management is an alternative investment manager with an approach to early stage venture capital investments targeting both financial and strategic returns for 'High Net Worth Individuals', corporate and institutional investments. The firm prefers to invest in the media, healthcare, diagnostics and life sciences, web application, software, mobile, communications and information technology sectors.